View all news

    New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of AntiCD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma

    12/04/2018
    Download(opens in new window)PDF 250 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com